IMPACT OF STROKE VOLUME ON CARDIOVASCULAR RISK IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY (A LIFE SUBSTUDY)

被引:0
|
作者
Lonnebakken, M. T. [1 ,2 ]
Gerdts, E. [1 ,2 ]
Boman, K. [3 ,4 ]
Wachtell, K. [5 ]
Dahlof, B. [6 ]
Devereux, R. B. [7 ]
机构
[1] Haukeland Hosp, N-5021 Bergen, Norway
[2] Univ Bergen, Bergen, Norway
[3] Skeleftea Cty Hosp, Umea, Sweden
[4] Umea Univ Hosp, Umea, Sweden
[5] Rigshosp, DK-2100 Copenhagen, Denmark
[6] Sahlgrens Univ Hosp, Gothenburg, Sweden
[7] Weill Cornell Med Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
下载
收藏
页码:S319 / S320
页数:2
相关论文
共 50 条
  • [31] Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study)
    Gerdts, Eva
    Cramariuc, Dana
    de Simone, Giovanni
    Wachtell, Kristian
    Dahlof, Bjorn
    Devereux, Richard B.
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2008, 9 (06): : 809 - 815
  • [32] Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE Trial)
    Gerdts, E
    Papademetriou, V
    Wachtell, K
    Nieminen, M
    Bjornstad, H
    Franklin, S
    Dahlof, B
    Devereux, RB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 448A - 448A
  • [33] Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertropy in hypertensive patients:: The LIFE study
    Okin, PM
    Devereux, RB
    Jern, S
    Julius, S
    Kjeldsen, SE
    Dahlöf, B
    AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (08) : 775 - 782
  • [34] Left ventricular walt stress-mass product in hypertensive patients with electrocardiographic left ventricular hypertrophy: The life study
    Devereux, RB
    Palmieri, V
    Okin, PM
    Boman, K
    Gerdts, E
    Nieminen, MS
    Dahlof, B
    CIRCULATION, 1999, 100 (18) : 604 - 604
  • [35] Detection of left ventricular hypertrophy during the assessment of cardiovascular risk in hypertensive patients
    Domenech, Monica
    Coca, Antonio
    MEDICINA CLINICA, 2014, 142 (06): : 253 - 254
  • [36] Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy -: The LIFE study
    Palmieri, V
    Okin, PM
    Bella, JN
    Gerdts, E
    Wachtell, K
    Gardin, J
    Papademetriou, V
    Nieminen, MS
    Dahlöf, B
    Devereux, RB
    HYPERTENSION, 2003, 41 (01) : 75 - 82
  • [37] Dissociation of arterial and myocardial involvement in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study
    Papademetriou, V
    Narayan, P
    Wachtell, K
    Devereux, RB
    Dahlof, B
    Messerli, FH
    CIRCULATION, 1999, 100 (18) : 181 - 181
  • [38] Ethnicity, left ventricular hypertrophy regression and cardiovascular events in the life echocardiography substudy
    Devereux, RB
    Wachtell, K
    Gerdts, E
    Wright, J
    Nieminen, MS
    Papademetriou, V
    Edelman, JM
    Boman, K
    Dahlof, B
    Harris, KE
    Julius, S
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 195A - 196A
  • [39] Myocardial performance index independently predicts cardiovascular morbidity and mortality in hypertensive patients with electrocardiographic left ventricular hypertrophy:: The LIFE study
    Wachtell, K
    Palmieri, V
    Gerdts, E
    Bella, JN
    Nieminen, MS
    Olsen, MH
    Poulsen, SH
    Arnlöf, J
    Papademetriou, V
    Dahlöf, B
    Devereux, RB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 227A - 227A
  • [40] The effect of losartan versus atenolol on hemostasis and fibrinolysis in hypertensive patients with left ventricular hypertrophy: A LIFE substudy
    Boman, KO
    Olsen, MH
    Wachtell, K
    Olofsson, M
    Ibsen, H
    Dige-Petersen, H
    Nilsson, TK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 482A - 482A